Targeted Drug Delivery Systems Precise drug delivery with significant reduction of side effects Every year, 10 million people die from cancer. Cancer is the second most common cause of death worldwide. Cancers affect people around the globe, and their numbers continue to rise, posing a huge challenge to healthcare systems. Despite advances in diagnosis and treatment, many types of cancer remain difficult to cure, and current therapies are often associated with severe side effects. Given the prevalence of this condition, there is a huge demand for effective and safe cancer treatments. At NanoVelos, we strive to meet this need by harnessing the potential of nanotechnology. NanoVelos technology is based on an innovative polysaccharide platform derived from dextran, effectively serving as a carrier for precise drug delivery. Thanks to a pH-dependent binding mechanism, therapeutic substances are selectively released in cancer cells, enhancing treatment efficacy while simultaneously reducing side effects. Toxic drug components accumulate within the diseased tissues rather than spreading throughout the entire body, significantly improving the safety profile of the therapy. Our carriers are synthesized without the use of metal particles or toxic substances, ensuring exceptional safety and biocompatibility. Additionally, their structure allows for the attachment of other substances. Thanks to patented technology, protected in many countries, NanoVelos offers a solution with vast potential applications. Nanotechnology is becoming one of the key directions in the development of modern medicine, and NanoVelos is setting new standards in this field. Our innovative approach to drug delivery opens new therapeutic possibilities, offering hope for more effective and safer treatment methods for patients worldwide.
